Status:
COMPLETED
Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Visual Impairment
Eligibility:
All Genders
18-90 years
Brief Summary
Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social dista...
Detailed Description
Project Title Validity of Home Visual Acuity Measurements with an ETDRS Chart Project Summary Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use ...
Eligibility Criteria
Inclusion
- The study population will include patients scheduled for in-person visits for various subspecialties (Glaucoma, Retina/Uveitis, pediatrics and Cornea) at Vanderbilt Eye Institute's (VEI) Nashville campus during the period of 4/27/20-5/8/20.
Exclusion
- Patients will be excluded if they have a last best corrected visual acuity worse than 20/200.
- If they have not activated a My Health at Vanderbilt (MHAV) account
- If they do not speak English.
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04391166
Start Date
May 20 2020
End Date
December 1 2020
Last Update
March 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Eye Institute
Nashville, Tennessee, United States, 37232